MedTrace Logo

Antioxidants vs. Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve

NCT03621683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2018-08-08

No results posted yet for this study

Summary

Two group of patients were selected. Group 1 represents 46 patients that received ovarian-biostimulation monthly for three months. Group 2 represents 32 patients that received antioxidant therapy daily for 3 months. Results are noted and analysed.

Both groups represent patients with procedures already ongoing, and with diagnosed poor or depleted ovarian reserve.

The analysis has been made to compare the efficacy of both procedures.

Conditions

  • Ovarian Reserve

Interventions

PROCEDURE

blood rich plasma platelets

Injection of blood rich platelet into the ovaries.

DIETARY_SUPPLEMENT

Antioxidant therapy

Antioxidants: Q10, DHEA, Vitamina E, Vitamin C, Omega 3

Sponsors & Collaborators

  • Lucy Coleman

    lead INDUSTRY

Principal Investigators

  • Carmen Navarro, MD · Medical staff

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
38 Years
Max Age
46 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-06
Primary Completion
2017-01-10
Completion
2017-08-28

Countries

  • Venezuela

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03621683 on ClinicalTrials.gov